肿瘤微环境中的代谢改变通过表观遗传修饰影响 CD8(+) T 细胞的抗肿瘤免疫功能

Metabolic reprogramming within the tumor microenvironment (TME) is a pivotal driver of CD8 + T cell dysfunction in cancer. Tumor cells outcompete T cells for essential nutrients, including glucose and amino acids, while accumulating immunosuppressive metabolites such as lactate and 2-hydroxyglutarate. Beyond direct functional impairment, emerging research reveals that these metabolic alterations orchestrate CD8 + T cell transcriptional programs by remodeling their epigenome- via histone modifications, DNA methylation, and non-coding RNA networks-thereby dictating their differentiation, cytotoxic potential, and memory formation.

A deeper understanding of how TME-derived metabolic signals shape the epigenetic landscape of CD8 + T cells is crucial for improving current cancer immunotherapeutic strategies. This review systematically delineates how key TME metabolic features, including nutrient deprivation and oncometabolite accumulation, regulate CD8 + T cell fate through epigenetic pathways.

Furthermore, we discuss promising therapeutic strategies that target the metabolism-epigenetics axis to reinvigorate CD8 + T cell anti-tumor immunity, offering novel perspectives for enhancing adoptive cell therapy and immune checkpoint blockade. In cancer, tumor cells create a harsh environment that weakens the body’s key fighter cells, known as CD8 + T cells. These T cells are essential for attacking and destroying cancer, but tumors outcompete them for vital nutrients and fill the area with suppressive chemicals.

Recent research shows that these chemical changes do more than just starve or poison the T cells. They actually rewire the T cells’ internal “control switches,” changing which genes are turned on and off. This rewiring dictates whether a T cell becomes a powerful attacker, gets exhausted, or forms a long-lasting memory. This article explains how the lack of nutrients and buildup of harmful chemicals in the tumor environment manipulate these control switches to impair T cell function.

We also discuss promising new treatment strategies that target this link between metabolism and control switches to reinvigorate T cells, with the goal of making current immunotherapies more effective.